Articles related to TYPE 2 DIABETES
Diabetes, Edentulism, and Cognitive Decline: A 12-Year Prospective Analysis
A study of nearly 10,000 adults aged 65 and older found that individuals with either complete tooth loss or diabetes had accelerated cognitive decline compared to those without the diseases. And decline was fastest for individuals 65-84 who had both conditions. The authors hypothesize a combination of nutritional deficiency and inflammation as playing a role.
Dentistry March 20th 2023
Getting to Know GLP-1 Receptor Agonists
Whether prescribing them for diabetes or weight loss, what factors should you consider when choosing among the seven approved GLP-1 agonist formulations? This concise review highlights the variables.
Endocrinology, Diabetes, Metabolism March 15th 2023
Vitamin D and Risk for Type 2 Diabetes in People with Prediabetes
The results of these trials show that vitamin D reduced the risk of diabetes progression by 3% to 18% after three years, with serum 25-hydroxy D levels of at least 125 nmol/L showing the greatest benefit. Vitamin D was also associated with a 30% increase in the likelihood of returning to normal glucose regulation.
Endocrinology, Diabetes, Metabolism February 23rd 2023
Brenzavvy Approved for Adults with Type 2 Diabetes
The SGLT2 inhibitor bexagliflozin is now available under the brand name Brenzavvy. Approval was based on monotherapy trials versus glimepiride, where the new drug was non-inferior, and in combination with metformin.
Endocrinology, Diabetes, Metabolism February 15th 2023
Diabetes Standards of Care 2023
Guideline Central offers a complete summary of the ADA’s latest guideline — Standards of Care for 2023. The update and summary cover topics from delaying the onset of T2DM to supporting positive behaviors, glycemic targets, weigh management, technology, pharmacology, and preventing and managing complications and concomitant diseases.
Clinical Pharmacology January 30th 2023
Saving Sight in Your Patients with Diabetes: What You Might Be Missing
Participants should be better able to discuss anti-VEGF therapy outcomes in patients with moderate-severe and severe nonproliferative diabetic retinopathy after taking part in this educational activity with Drs. Susan Bressler, Mark Dunbar, and Ruth Weinstock, and understand the importance of prompt referral and early diagnosis to reduce or even prevent the vision-threatening complications of diabetes.
Endocrinology, Diabetes, Metabolism January 26th 2023